Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early antipsychotic switch versus maintenance in early non-responders with schizophrenia
2009-012031-15Phase 4Completed
- Sponsor
- Technical University of Munich
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of olanzapine and amisulpride in schizophrenia, schizophreniform disorder and schizoaffective disorder (4 arms), sponsored by Technical University of Munich. Primary endpoint: Remission after 8 weeks. Started Jul 2009; status: completed.
02
Drugs
olanzapineamisulpride
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on 2009-012031-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012031-15.